Villepreux, France

Patrick Bernardelli

This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Sanofi-Aventis, Aventis Pharmaceuticals Inc.. Active years: 2009-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Bernardelli. Retrieved from https://idiyas.com/inventor/patrick-bernardelli-x5k0iqyb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Villepreux, FR (2009 - 2010)
  • Paris, FR (2010)

Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Patrick Bernardelli: Innovator in Pharmaceutical Chemistry

Introduction

Patrick Bernardelli is a notable inventor based in Villepreux, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of six patents. His work primarily focuses on compounds that have therapeutic applications in treating various metabolic and neurodegenerative disorders.

Latest Patents

Among his latest patents, Bernardelli has developed phenyl-1,2,4-oxadiazolone derivatives with a phenyl group. These compounds, along with their physiologically acceptable salts, exhibit PPARdelta agonist activity. They are designed for the treatment and prevention of disorders related to fatty acid metabolism and glucose utilization, as well as conditions involving insulin resistance and neurodegenerative disorders. Another significant patent involves phenyl-[1,2,4]-oxadiazol-5-one derivatives, which also target similar health issues. These inventions highlight his commitment to advancing pharmaceutical solutions for complex health challenges.

Career Highlights

Throughout his career, Patrick Bernardelli has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Bernardelli has collaborated with esteemed colleagues such as Stefanie Keil and Wolfgang Wendler. These partnerships have contributed to the successful development of his patented compounds and have enhanced the impact of his work in the pharmaceutical field.

Conclusion

Patrick Bernardelli's innovative contributions to pharmaceutical chemistry demonstrate his dedication to improving health outcomes through scientific research and development. His patents reflect a deep understanding of complex medical conditions and a commitment to finding effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…